Navigation Links
Cancer diagnosis isotopes from Garching
Date:6/27/2011

This release is available in German.

The German Federal Ministry of Health has awarded more than one million euros in research and development funding for the efficient production of an important cancer diagnostic agent at the research neutron source FRM II. In a 2009 feasibility study, the Technische Universitaet Muenchen demonstrated that due to the high neutron flux the neutron source in Garching can produce about half of the European demand of the radioisotope molybdenum-99.

Approximately seventy thousand patients undergo scintigraphic tests every day throughout the world. About 70 percent of these tests are performed with technetium-99m for the diagnosis of tumors. Necessary for the production of technetium-99m is its parent isotope molybdenum-99, most of which is produced in just five neutron sources worldwide. If production at one of these sources temporarily pauses, vital investigations have to be postponed. Therefore nuclear medicine physicians have long been calling for an upgrade of the Garching research neutron source for production of molybdenum-99.

Now the Federal Health Ministry has pledged to support the development of an efficient radiation process at Garching's research neutron source. Subsidies amounting to one million euros are allocated for the years 2011 and 2012. In addition, the State of Bavaria is supporting the construction with 1.2 million euros for personnel and material resources.

During the current ongoing maintenance and upgrading work, the FRM II has already installed a thimble in which the molybdenum-99 will be produced in the future. The aim of further research is to produce significantly higher specific activity than existing production facilities. This includes not only measures for efficient cooling of the material in a position with highest neutron flux, but also more efficient packaging processes for safe and speedy delivery of the short-lived isotope for further radiopharmaceutical processing.

The Scientific Director of the FRM II, Prof. Dr. Winfried Petry, said: "The funding helps us to develop more efficient methods for the production of the isotope. Therewith Germany provides an important contribution to Europe's supply of radioisotopes for nuclear medicine."

Already in clinical use, there is another isotope that is produced at TUM's neutron source, lutetium-177. It is mainly used to treat endocrine tumors such as gastrointestinal tumors. In cooperation with the firm Isotope Technologies Garching GmbH (ITG), the research neutron source produces lutetium-177 for the treatment of about 50 patients per week.


'/>"/>

Contact: Dr. Andreas Battenberg
battenberg@zv.tum.de
49-892-891-0510
Technische Universitaet Muenchen
Source:Eurekalert  

Related medicine news :

1. Duke team finds new clues to how cancer spreads
2. Nearly Half of Older Breast Cancer Patients Dont Get Radiation
3. Scientists identify a novel mechanism for evolution of highly aggressive cancers
4. Many advanced breast cancer patients do not receive recommended treatment
5. Lifestyle Changes Might Alter Breast Cancer Rates
6. New breast cancer risk model quantifies the impact of risk reduction
7. Hereditary colon cancer syndrome marked by abnormally dense blood vessel growth in mouth
8. UH Cancer Center receives $3.58 million gift for mesothelioma research
9. New insights into origin of deadly cancer
10. Marriage Might Boost Colon Cancer Survival
11. Leftover embryonic cells connect gastric reflux and cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cancer diagnosis isotopes from Garching
(Date:5/28/2016)... ... May 28, 2016 , ... SuperCloset is proud to officially launch our ... to day issues, struggles and obstacles veterans’ need to overcome in order to face ... active or retired military veteran(s) with a donated SuperCloset product based on the needs ...
(Date:5/28/2016)... ... ... After a year and a half of planning the Multiple Pathways of Recovery Conference ... of Recovery Conference was held May 2 -4, 2016 at the Mystic Marriott Hotel ... to explore the many pathways individuals use to get into and sustain their recovery. ...
(Date:5/27/2016)... ... ... Southland Log Homes , designer and manufacturer of America’s Favorite Log ... be found on its website at SouthlandLogHomes.com. , The designs of the wood ... craftsmanship of timber post and beam construction. The result is a barn that ...
(Date:5/27/2016)... ... May 27, 2016 , ... An influential resource amongst nurses and ... to shed lights on the variety of topics detailing why we appreciate nurses in ... why this career has gone from being in a major recession to one of ...
(Date:5/27/2016)... New York, NY (PRWEB) , ... May 27, ... ... caregivers to casual readers, this installment is bolstered by inspiring human-interest stories, courtesy ... trends and tech within the industry, from leading advocates, associations and industry leaders ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... 24, 2016 ARANZ Medical  Ltd ... healthcare sector, has been named the Coretex Hi-Tech Emerging Company ... Dr Bruce Davey , CEO of ARANZ ...  It,s really good to be recognised for the work we ... are used in 35 countries around the world from Sub-Saharan ...
(Date:5/24/2016)... 24, 2016 Celsion Corporation (NASDAQ: ... today provided an update on its ongoing OVATION ... combining GEN-1, the Company,s DNA-based immunotherapy, with the ... patients with advanced ovarian cancer who will undergo ... is an IL-12 DNA plasmid vector formulated as ...
(Date:5/24/2016)... KONG , May 24, 2016 ... , the world , s first ... AV fistula intervention   OrbusNeich, a global ... has expanded its portfolio to include products to treat ... are the company,s first entry devices for lower limb ...
Breaking Medicine Technology: